The latest news, announcements and press releases from UroGen Pharma, Inc.
Amid the COVID-19 pandemic and resulting quarantines, it would be easy to overlook an FDA approval of a reformulated chemotherapy drug to treat a rare cancer. But UroGen investors were certainly ready to welcome good news, and they got it yesterday evening when the FDA approved the company’s first drug, Jelmyto.
This is the News section of the company profile page for UroGen Pharma, Inc on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.